Bukwan agreed to transfer technology of Clebutine.

Published: 2005-06-29 06:59:00
Updated: 2005-06-29 06:59:00
Bukwang made a technical transfer agreement with American Pharmasset Inc. for Clebutine, a drug for B viral hepatitis, on June 24.

The agreement granted Pharmasset to distribute Clebutine in other countries except Asia, including North, Middle, South America, Europe, Caribbean and Israel at th...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.